Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

109.30 +3.21 (+3.03%)

Official Closing Price Updated: 7:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

52 53 Next >

GE Healthcare Technology: Speculating On Dividends

January 30, 2023

GE Healthcare released a solid report and gave steady guidance that includes ample room in the cash flow for a dividend, should the board choose to pay one.

Via MarketBeat

Is Abbott Laboratories a Good Dividend Stock to Buy Now? ↗

January 28, 2023

At least four Wall Street banks recently raised their price targets for the healthcare giant.

Via The Motley Fool

Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review ↗

January 27, 2023

Stocks reacted well to uneven earnings and economic reports.

Via Investor's Business Daily

What 5 Analyst Ratings Have To Say About Abbott Laboratories ↗

January 26, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years ↗

January 25, 2023

Via Benzinga

What's Going On With Abbott Laboratories Stock Today? ↗

January 25, 2023

Abbott Laboratories (NYSE: ABT) shares are trading lower Wednesday in the wake of the company's quarterly results.

Via Benzinga

NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday ↗

January 26, 2023

Keybanc raised the price target for D.R. Horton, Inc. (NYSE: DHI) from $97 to $109. Keybanc analyst Kenneth Zener maintained an Overweight rating. D.R. Horton shares fell 1.6% to close at $95.48 on...

Via Benzinga

Abbott's Sales and Earnings Are Sinking: Should Investors Worry? ↗

January 26, 2023

There's more to the story than the negative trends for Abbott's top and bottom lines.

Via The Motley Fool

Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?

January 26, 2023

Johnson & Johnson and Abbott Laboratories are 2 dividend kings guiding for growth in 2023 and are on track to increase their yield yet again.

Via MarketBeat

Topics Economy

Why Abbott Laboratories Stock Got Whacked on Wednesday ↗

January 25, 2023

Double beats for its latest quarter couldn't keep the bears away from the company's shares on Hump Day.

Via The Motley Fool

Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript ↗

January 25, 2023

ABT earnings call for the period ending December 31, 2022.

Via The Motley Fool

Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth ↗

January 25, 2023

Overall sales topped forecasts, but organic growth missed expectations.

Via Investor's Business Daily

A Bullish Sign Appears On Abbott Laboratories's Chart ↗

January 24, 2023

Via Benzinga

Earnings Outlook For Abbott Laboratories ↗

January 24, 2023

Via Benzinga

Why Aurora Cannabis Stock Is Fading Today ↗

January 25, 2023

With discretionary spending under pressure, investors are shying away from this Canadian cannabis stock today.

Via The Motley Fool

Abbott Q4 Earnings And Revenues Top Estimates ↗

January 25, 2023

Abbott came out with quarterly earnings of $1.03 per share.

Via Talk Markets

Microsoft's Gloomy Guidance, Boeing's Surprise Q4 Loss Pulls Market Lower ↗

January 25, 2023

(Wednesday Market Open) The market gives and the market takes away.

Via Benzinga

Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February ↗

January 25, 2023

U.S. stocks look set to start Wednesday’s session on the back foot as traders digest mixed earnings news flow and continued pouring in of weak economic data points. Cues From Tuesday’s Trading:

Via Benzinga

Earnings Scheduled For January 25, 2023 ↗

January 25, 2023

Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is expected to report quarterly earnings at $4.45 per share on revenue of $6.50 billion.

Via Benzinga

Investor Optimism Declines Following Earnings Reports ↗

January 25, 2023

The CNN Money Fear and Greed index showed some decline in overall market sentiment among US investors. US stocks closed mixed on Tuesday as investors assessed the latest corporate earnings.

Via Benzinga

Abbott Laboratories, QUALCOMM, GE HealthCare Technologies And This Subsidiary Of Diamondback Energy On CNBC's 'Final Trades' ↗

January 24, 2023

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Viper Energy Partners LP (NASDAQ: VNOM), which is a subsid

Via Benzinga

Stocks Make a Quiet Move Upward Ahead of Thursday's GDP, 'Pause' Talk ↗

January 23, 2023

(Monday Market Open) This week and next could go a long way toward determining how the current quarter plays out on Wall Street.

Via Benzinga

Spotify To Downsize Employee Count, Activist Investor Elliott Invests Multibillion Dollars In Salesforce, Abbott Draws DOJ Investigation On Baby Formula Plant Shutdown: Today's Top Stories ↗

January 23, 2023

Reuters Juul's Consumer Settlement Is 'Reasonable & Adequate,' US Judge Says

Via Benzinga

Want Safe and Growing Passive Income? Buy These 2 Dividend Kings In 2023 ↗

January 23, 2023

It doesn't get any safer for income investors than Dividend Kings.

Via The Motley Fool

6 Dividend Growth Stocks ↗

January 22, 2023

Interested in knowing about companies that are paying their shareholders even bigger dividends than before? Today I want to tell you about six dividend growth stocks that just increased their...

Via Talk Markets

Tesla, Microsoft, IBM, Intel, TI Among Companies Reporting This Week: Can Netflix's Optimism Spill Over To Rest Of Tech Space? ↗

January 22, 2023

Netflix, Inc. (NASDAQ: NFLX) shares jumped nearly 8.5% on Friday before settling at their highest level since April 19, 2022, when shares plunged after the company reported its first loss in net paid...

Via Benzinga

Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report ↗

January 21, 2023

The Justice Department's consumer-protection branch is conducting an investigation into infant formula maker Abbott Laboratories (NYSE: ABT).

Via Benzinga

ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

January 19, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

3 Top Passive-Income Stocks to Own in 2023 ↗

January 19, 2023

These stocks can add safety and growth to your portfolio.

Via The Motley Fool

AbbVie Stock: Dividend King ABBV Overview

January 19, 2023

Via MarketBeat

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

52 53 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.